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Retinopathy of prematurity (ROP) is the main cause of blindness and visual impairment in Latin 2 
America and prevention, detection and treatment have been a priority in the Region in the last two 3 
decades. There is progress in the number of eligible babies screened and treated in at least half of the 4 
countries with strong regulations on ROP, but screening is not yet available in all provinces in most.  5 
More effort is needed to increase national protocols and legislation, strengthening of services and 6 
human resources to cover all national provinces, telemedicine might be a promising strategy. 7 
 8 
Introduction  9 
Retinopathy of prematurity (ROP) is a major cause of blindness and visual impairment in children in 10 
Latin America being responsible for 16.6% of blindness in Chile, 11.8%  in Sao Paulo, Brazil and 11 
34.7% in Guadalajara, Mexico.1-3 Studies from a number of countries of preterm infants with a birth 12 
weight of < 1,500 g, found the incidence of any stage ROP varied from 10% to 71%, and the 13 
incidence of treatable ROP varied from 1.2% to 19%.4  14 
 15 
An earlier study in Latin America and the Caribbean showed that a higher proportion of eligible 16 
babies were screened in countries with government policies mandating and financing screening, 17 
which had clinical guidelines and where ROP was included in national health information systems.5 In 18 
a worldwide survey of ROP, nine Latin American countries responded that they had national ROP 19 
protocols,6 but information was not provided on the availability of ophthalmologists to screen, nor 20 
whether countries had a national ROP screening programme.     21 
Methods  22 
This paper summarizes the recent published data on the situation of ROP legislation, guidelines and 23 
programme development in Latin America. To obtain additional information, the Pan American 24 
Health Organization (PAHO) distributed a survey to national members of the Pan American Society 25 
of Retinopathy of Prematurity in all 19 countries in the region in 2018, to obtain information on the 26 
number of ophthalmologists performing diagnostic examination, the number of NICUs implementing 27 
ROP programmes at subnational level and the use of telemedicine in the screening. 28 
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Regional Response 1 
The control of blindness from ROP has been a regional priority since the nineties when ROP was 2 
identified as an important cause blindness in children,7 and was included in PAHO Action Plans for 3 
the Prevention of Blindness in 2009-20138 and 2014-2019.9  Ministers of Health across the region 4 
approved these plans which are being implemented with support from PAHO, the International 5 
Agency for the Prevention of Blindness, international non-government organizations,  worldwide 6 
experts and the Pan American Society of Retinopathy of Prematurity.  In 2017, PAHO worked with a 7 
multi-disciplinary, international group to develop evidence-based guidelines for ROP to serve as a 8 
regional standard.10   9 
National response  10 
Normative  11 
In the earlier study in ten Latin America countries, a higher proportion of eligible preterm newborns 12 
were being screened and treated in countries with (i) policies  on financing mechanisms  for screening 13 
and treatment, (ii) national ROP guidelines (iii) legislation mandating eye screening and (iv) 14 
management systems for data collection and analysis.5 In Argentina, crucial factors which led to 15 
scaling up services for ROP included a dedicated group of professionals, the Ministry of Health, a 16 
national ROP committee, international cooperation for norms development and programme 17 
implementation, and external funding for a limited period of time.11 Several countries in the region 18 
have national clinical guidelines which were developed using the GRADE methodology, in Argentina 19 
in 2016,12 Mexico Ministry of Health in 201013 and Social Security in 201514. Chile has an expert 20 
review guidelines,15 whilst guidelines from Costa Rica, Cuba, El Salvador and Nicaragua exist but are 21 
not publicly available on the internet. The criteria for screening in these guidelines vary from <1,500 22 
to <2,000 g, and from <32 to <34 weeks gestational age, and recommend screening preterm infants at 23 
any birth weight who have risk factors such as sepsis and transfusion of blood products.    24 
Plans and Programmes  25 
Nine of the nineteen countries collected and submitted the information requested in this survey 26 
whereas Chile and Argentina routinely collect data. In Chile, the programme is established in all 27 
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regions, and in eight provinces screening is by imaging and telemedicine with ophthalmologist 1 
readers, which has proved to be effective.16 In Argentina in 2018, 114 neonatal intensive care units 2 
(NICUs), comprising most of the government sector, and 119 ophthalmologists have been 3 
implementing screening and treatment in all provinces since 2016.17 4 
Over 60% of provinces/regions in Bolivia, Costa Rica and Nicaragua have at least one NICU doing 5 
ROP screening, and in about half of provinces/regions in Paraguay and Peru. El Salvador and 6 
Guatemala have less than 50% of provinces/regions implementing a programmme (Table 1).  7 
 8 
Table 1. Policies mandating screening and provinces/regions with at least one hospital doing 9 
screening 10 
Country 
Policies mandating the 




screening (N, %) 
Argentina Yes 24 24 (100%) 
Bolivia No 9 6 (67%) 
Chile Yes 16 16 (100%) 
Costa Rica Yes 7 5 (71%) 
El Salvador Yes 14 5 (36%) 
Guatemala No 22 9 (41%) 
Nicaragua No 17 12 (71) 
Paraguay No 18 9 (50) 
Peru No 25 13 (52) 
 11 
Nine countries had information on the number of NICUs with ROP screening and the number of 12 
ophthalmologists doing screening. The number of preterm babies per ophthalmologist screener varies 13 
and there is estimated to be one ophthalmologist per 108 preterm babies in Argentina and one per 250 14 
preterm babies in Chile (Table 2). Both these countries have programmes which cover all provinces / 15 
regions, and Chile has a highly developed telemedicine program. In Guatemala there are estimated to 16 
be 474 babies per ophthalmologists doing screening, and if each baby is examined 3 times this would 17 
result in a workload of 27 preterm babies per ophthalmologists per week.. This workload would be 18 
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manageable if each ophthalmologist dedicates most of their time in ROP screening and treatment and 1 
if the babies are in very few large NICUs nearby, but this is rarely the case.    2 
 3 
Table 2: Number of NICUs with ROP screening, number of ophthalmologists doing screening, 4 






















      <37 wks2  <34 wks
3
       
Argentina1 114 119 60.900 20.097 16.078 12.862 108 
Bolivia 9 10 22.100 7.293 5.834 4.668 467 
Chile1 24 14 16.600 5.478 4.382 3.506 250 
Costa Rica1 9 11 9.300 3.069 2.455 1.964 179 
El Salvador 7 8 13.400 4.422 3.538 2.830 354 
Guatemala 9 16 35.900 11.847 9.478 7.582 474 
Nicaragua 14 18 11.100 3.663 2.930 2.344 130 
Paraguay1 11 28 10.500 3.465 2.772 2.218 79 
Peru1 31 35 45.700 15.081 12.065 9.652 276 
1 Countries using digital imaging with remote reading  
2 Preterm births in 2015 www.everywomaneverychild.org/wp.../Country-data-for-WPD-2016-Excel-doc.xlsx 
3 33% estimate  
A tele-education system for ROP was effective in improving the diagnostic accuracy and management 6 
of ROP by ophthalmologists-in-training in Mexico.18 7 
Monitoring  8 
The regional ROP guidelines recommend collecting data on the number of preterm newborns who are 9 
eligible for screening, the number examined, the number with ROP of any stage, the number with 10 
indications for treatment and number treated, to construct the following indicators, (1) coverage of 11 
screening, (2) proportion of preterm infants with any stage of ROP, and (3) treatment coverage for 12 
ROP.10    13 
Since 2004 the national programme in Argentina has collected annual data and produces a report, with 14 
the indicators from 98 hospitals in 24 provinces reported in 2016. From 2004 to 2016, the mean birth 15 
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weight of newborns with any ROP decreased by 200 g and the mean GA reduced by 3 weeks. In 1 
addition, the proportion of babies treated for ROP with BW >1500 g or >32 weeks of gestational age 2 
was 30% in 2004, which rose  to a peak of 40% in 2006 and progressively declined to 17 % (44/ 253) 3 
in 2016.17  These changes almost certainly reflect improvements in neonatal care. Costa Rica has 4 
documented risk factors for ROP, and the results of ROP screening and treatment between 2010 and 5 
2014,19 and Colombia uses the national health information system (ASIS) to collect data on the 6 
number of live born babies with birth weight <1,999 g with a diagnosis of ROP; in 2014 it was 7 
8.3%.20   Some countries have assessed their ROP programme in a selected group of NICUs; in 7 units 8 
in Rio de Janeiro, Brazil in 2010 to identify the characteristics of preterm infants at risk of ROP,21 in 6 9 
units in Lima, Peru in 2012,22  and in 32 units in Mexico in 2015. 23  10 
Comment 11 
 12 
Latin America has experienced a strong regional direction, advocacy and support from international 13 
allies and experts, the Ministries of Health are introducing protocols and regulations and making 14 
important financial allocations for the incorporation of ROP services into neonatal care. Almost half 15 
of the countries have an inventory on the number of NCIUs and ophthalmologists implementing a 16 
ROP programme at the subnational level and are using telemedicine in the screening. Argentina and 17 
Chile have a national steering committee that plan and implement activities to strengthening services 18 
and human resources to cover all national provinces/regions and collect, analyses and uses data. The 19 
countries with less development in ROP programs would require developing protocols and regulations 20 
and stewardship for services and human resources development at the subnational level. Further 21 
research is needed on adherence to national or international guidelines in regions/provinces.   22 
 23 
It is not possible to recommend the ideal number of ophthalmologists who should screen for ROP, as 24 
this is influenced not only by the number of preterm infants who survive but also by the distribution 25 
of NICUs and of ophthalmologists. Assuming each preterm infant needs an average of three 26 
examinations, the workload in terms of the number of preterm infants who need to be screened each 27 
week would very high in some countries in the region and more ophthalmologist need to be trained in 28 
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ROP screening. Much of this shortfall could be addressed by neonatology-led screening using wide-1 
field imaging whereby members of the neonatal team take the images which are either interpreted by 2 
the team, which would require rigorous quality assurance systems, or are remotely interpreted by ROP 3 
experts. 24 Almost real-time image analysis using artificial intelligence is also on the horizon 25. These 4 
advances in combination have great potential to increase access to high quality, reliable screening. 5 
 6 
 7 
Funding: This study received no specific grant from any funding agency in the public, commercial or 8 
not-for-profit sectors. 9 
 10 




  15 
8 
 
References  1 
 2 
1. Gilbert CE, Canovas R, Hagan M, Rao S, Foster A. Causes of childhood blindness: Results from 3 
west Africa, south India and Chile. Eye (1993) 7, 184-188 4 
 5 
2. Haddad MA, Sei M, Sampaio MW, Kara-José N. Causes of visual impairment in children: a 6 
study of 3,210 cases. J Pediatr Ophthalmol Strabismus. 2007 Jul-Aug;44(4):232-40 7 
 8 
3. Zepeda-Romero LC, Barrera-de-Leon JC, Camacho-Choza C, Gonzalez Bernal C, Camarena-9 
Garcia E, Diaz-A; Latorre C et al. Retinopathy of prematurity as a major cause of severe visual 10 
impairment and blindness in children in schools for the blind in Guadalajara city, Mexico Br J 11 
Ophthalmol 2011;95:1502e1505. doi:10.1136/bjophthalmol-2011-300015 12 
 13 
4. Carrion JZ, Fortes Filho JB, Tartarella MB, Zin A, Jornada ID Jr. Prevalence of retinopathy of 14 
prematurity in Latin America. Clin Ophthalmol 2011;5:1687-95.  15 
 16 
5. Arnesen L, Durán P, Silva J, Brumana L. A multi-country, cross-sectional observational study of 17 
retinopathy of prematurity in Latin America and the Caribbean. Rev Panam Salud Publica. 2016 18 
Jun;39(6):322-329  19 
 20 
6. Mora JS, Waite C, Gilbert CE, Breidenstein B, Sloper JJ. A worldwide survey of retinopathy of 21 
prematurity screening. 2018 Jan;102(1):9-13. doi: 10.1136/bjophthalmol-2017-310709. 22 
 23 
7. Gilbert C, Rahi J, Eckstein M, O´Sullivan J, Foster A. Retinopathy of prematurity in middle-24 
income countries. The Lancet Volume 350, Issue 9070, 5 July 1997, Pages 12-14 25 
 26 
8. Pan American Health Organization. Plan of Action for the Prevention of Blindness and Visual 27 
Impairment 2009-2013. Proceedings of the 49th Directing Council of PAHO, 61th Session of the 28 
Regional Committee of WHO for the Americas. 28 September-2 October 2009. Washington: 29 
PAHO, 2009.  http://www1.paho.org/hq/dmdocuments/2010/CD49-19-e[1].pdf 30 
 31 
9. Pan American Health Organization. Plan of Action for the Prevention of Blindness and Visual 32 
Impairment 2014-2019. Proceedings of the 53rd Directing Council of PAHO, 66th Session of the 33 
Regional Committee of WHO for the Americas; 29 September–3 October 2014. Washington: 34 




10. Pan American Health Organization. Guía de práctica clínica para el manejo de la retinopatía de la 39 
prematuridad. Washington D.C: USA, 2017  http://iris.paho.org/xmlui/handle/123456789/34948 40 
 41 
11. Hariharan L, Gilbert CE, Quinn GE, Barg FK, Lomuto C, Quiroga A et al.  Reducing blindness 42 
from retinopathy of prematurity (ROP) in Argentina through collaboration, advocacy and policy 43 
implementation. Health Policy and Management. 2018 Jun 1;33(5):654-665. doi: 44 
10.1093/heapol/czy004 45 
 46 
12. Ministerio de Salud de Argentina & Grupo ROP. Guía de Práctica Clínica para la prevención, 47 
diagnóstico y tratamiento de la Retinopatía del Prematuro (ROP) Buenos Aires, Argentina: 48 
Ministerio de Salud; 2016. 49 
http://www.msal.gob.ar/images/stories/bes/graficos/0000000723cnt-guia-rop-2016.pdf 50 
 51 
13. Secretaria de Salud de México. Detección, diagnóstico y tratamiento de retinopatía del 52 







14. Instituto Mexicano del Seguro Social. Detección, diagnóstico y tratamiento de retinopatía del 4 
prematuro en el segundo y tercer nivel de atención. México: Instituto Mexicano del Seguro 5 
Social; 2015. ISBN: 978-607-8392-49- 6 
a. http://www.imss.gob.mx/sites/all/statics/guiasclinicas/281GER.pdf 7 
 8 
15. Ministerio de Salud de Chile. Guia Clinica Retinopatia del Prematuro. Ministerio de salud de 9 
Chile. Santiago: Minsal, 2010. 10 
https://www.minsal.cl/portal/url/item/721fc45c973b9016e04001011f0113bf.pdf 11 
 12 
16. Ossandon D, Zanolli M, Stevenson R, Agurto R, Ortiz P, Dotan G.  A national telemedicine 13 
network for retinopathy of prematurity screening. J AAPOS. 2018 Apr;22(2):124-127. doi: 14 
10.1016/j.jaapos.2017.11.005. 15 
 16 
17. Alda E, Lomuto CC, Benítez AM, Bouzas L, Brussa M, Cattaino A, et al. Results of the National 17 
Program for the Prevention of Blindness in Childhood by Retinopathy of Prematurity in 18 




18. Patel SN, Martinez MA, Berrones D, Swan R, Ryan MC, Jonas KE, et al.  Assessment of a Tele-23 
education System to Enhance Retinopathy of Prematurity Training by International 24 
Ophthalmologists-in-Training in Mexico. Ophthalmology. 2017 Jul;124(7):953-961. doi: 25 
10.1016/j.ophtha.2017.02.014 26 
 27 
19. Tabarez-Carvajal AC, Montes-Cantillo M,1 Unkrich KH, Trivedi RH, Peterseim MMW.  28 
Retinopathy of prematurity: screening and treatment in Costa Rica. Br J Ophthalmol. 2017 29 
Dec;101(12):1709-1713. doi: 10.1136/bjophthalmol-2016-310 30 
 31 
20. Ministerio de Salud y Protección Social de Colombia. Programa Nacional de Atención Integral 32 




21. Zin AA, Moreira ME, Bunce C, Darlow BA, Gilbert CE. Criteria and workload implications 37 
retinopathy of prematurity in 7 neonatal units in Rio de Janeiro: screening criteria and workload 38 
implications. Pediatrics. 2010 Aug;126(2):e410-7. doi: 10.1542/peds.2010-0090. 39 
 40 
22. Gordillo L, Villanueva AM, Quinn GE.  A practical method for reducing blindness due to 41 
retinopathy of prematurity in a developing country. J Perinat Med. 2012 Sep 4;40(5):577-82. doi: 42 
10.1515/jpm-2011-0225 43 
 44 
23. Zepeda C, Gilbert C. Limitations in ROP Programs in 32 Neonatal Intensive Care Units in Five 45 
States in Mexico. BioMed Research International. Volume 2015, Article ID 712624, 8 pages. 46 
https://www.hindawi.com/journals/bmri/2015/712624/ 47 
 48 
24. Gilbert C, Wormald R, Fielder A, Deorari A, Zepeda-Romero LC, Quinn G, et al. Potential for a 49 
paradigm change in the detection of retinopathy of prematurity requiring treatment. Arch Dis 50 




25. Wang J, Ju R, Chen Y, Zhang L, Hu J, Wu Y, et al . Automated retinopathy of prematurity 1 
screening using deep neural networks. EBioMedicine. 2018 Sep;35:361-368. doi: 2 
10.1016/j.ebiom.2018.08.033. Epub 2018 Aug 27. 3 
